Enhancing Personalized Medicine with Cardiovascular Genomics - Insights
PACE / State of FLIn this month’s “Virtual Lecture” Linnea Baudhuin, Ph.D., professor of laboratory medicine and pathology in the division of laboratory genetics and genomics, discusses inherited cardiovascular conditions and identifies...
The Secrets of Cryoprecipitate: A Blood Banking Process - Insights
In this month’s “Hot Topic,” Jessie Swanson and Michelle Soland from the Component Laboratory will discuss the process improvement that helped decrease the standard cryoprecipitate dosage and the positive impact it has on patients.
IgA-mediated autoimmune bullous dermatoses - Insights
In this month’s “Hot Topic,” Julia Lehman, M.D., will discuss autoimmune bullous dermatoses, the rare category of blistering skin diseases that are caused by the development of autoantibodies against various constitutive parts of the...
Email Management and Tips - Insights
Opening your email inbox is like being dealt a hand of cards. You don’t know what you’ll get, you may be caught off guard, and you need to determine how to play out the hand you’ve been dealt. Thomas Huntley, MT(ASCP), Education...
Mayo Clinic Laboratory and Pathology Research Roundup: Nov. 12 - Insights
This week’s Research Roundup highlights a mechanism for preventing asymmetric histone segregation onto replicating DNA strands.
Learn how reliable laboratory diagnosis of a platelet disorders can impact patients’ and their family members' clinical management and outcomes.
Talking omicron with Matthew Binnicker, Ph.D. - Insights
With the omicron variant grabbing headlines around the world, media outlets have turned to experts like Dr. Binnicker to help clarify the effect this new variant could have and what it might mean for the COVID-19 pandemic.
Opioids remain a mainstay of pain management, upping the stakes for monitoring prescription compliance and detecting abuse. Paul Jannetto, Ph.D., Director of the Clinical and Forensic Toxicology Laboratory at Mayo Clinic, and Loralie...
Epic journey yields unique offering - Insights
The quest to create a test pinpointing the source of the rare, testicular cancer-associated illness successfully concluded in the summer of 2021.
Cross-laboratory collaboration accelerates gold-standard SRA testing - Insights
Utilizing testing capabilities of two separate laboratory facilities, Mayo Clinic Laboratories’ new serotonin release assay (SRA) is a gold-standard test supported by decades of clinical hematopathologic experience and advanced mass...